Table 1.
Total (n = 33) | |
---|---|
Sex | |
Male | 24 (73%) |
Female | 9 (27%) |
Median age (IQR) | 69 (59.5–75.5) |
Median BMI (IQR) | 29 (25.6–31) |
ASA grade | |
I | 1 |
II | 27 |
III | 4 |
IV | 0 |
Neo adjuvant chemoradiotherapy | 11 (33%) |
Total (n = 33) | |
---|---|
Sex | |
Male | 24 (73%) |
Female | 9 (27%) |
Median age (IQR) | 69 (59.5–75.5) |
Median BMI (IQR) | 29 (25.6–31) |
ASA grade | |
I | 1 |
II | 27 |
III | 4 |
IV | 0 |
Neo adjuvant chemoradiotherapy | 11 (33%) |